Recently, the Dutch company Ellogon.AI visited Yancheng for inspection and negotiation, and signed a framework agreement on the settlement of the artificial intelligence-assisted medical project with Yancheng High-tech Zone on March 2. Shen Zhenxing, Member of the Standing Committee of the Yandu District Party Committee and Deputy District Mayor, Jiang Chunlei, a Level Ⅳ Division Rank Official of the Municipal Foreign Affairs Office, and other guests attended the signing ceremony. Both sides to the signing expressed that they will work together to promote the early implementation of the project and enable the relevant technologies to better serve Chinese patients.

The headquarters of the Dutch company Ellogon.AI is located in Amsterdam, the Netherlands. It is a company focusing on using artificial intelligence technology to screen suitable patients in cancer immunotherapy. Through a breakthrough deep learning method developed in cooperation with the Netherlands Cancer Institute and University of Amsterdam, the company can quickly and accurately quantify relevant biomarkers, and has significant technical advantages and great development potential in the field of cancer immunotherapy.